Technologies
When will the COVID vaccine be available for kids under 5?
Pfizer asks the FDA to authorize its vaccine for kids ages 6 months to 5 years. Here’s what we know about the FDA timeline, boosters for older kids and more.
Pfizer and BioNTech on Tuesday submitted data to the US Food and Drug Administration for authorization of their COVID-19 vaccine for children 6 months through 4 years old. While the vaccine for children under 5 is expected to be a three-dose vaccine series (it’s one-tenth the volume of Pfizer’s vaccine for people 12 and up), the FDA asked the companies to submit data on the first two doses as part of a “rolling submission” process.
“Having a safe and effective vaccine available for children in this age group is a priority for the agency and we’re committed to a timely review of the data, which the agency asked Pfizer to submit in light of the recent omicron surge,” Dr. Janet Woodcock, FDA commissioner, said in a statement Tuesday. “Furthermore, children are not small adults. Because they’re still growing and developing, it’s critical that these vaccines are evaluated in well-designed and well-conducted clinical trials.”
In December, Pfizer announced that while two doses of the vaccine were effective in children ages 6 months to 2 years, two shots failed to promote a strong enough immune response in children ages 2 through 4 years. This prompted the company to start testing a three-dose version of the vaccine for children under 5. In the coming months, that data will also be submitted to the FDA for authorization, and is expected to complete the vaccine series.
Kids as young as 5 have been able to be vaccinated against COVID-19 since October — as of Dec. 19, more than 8.7 million vaccine doses have gone out to kids 5 to 11. And kids as young as 12 are eligible for booster shots, after they were recommended by the US Centers for Disease Control and Prevention in January. As the COVID-19 landscape continues to evolve, here’s what we know about COVID-19 vaccines for kids and teens. Plus, learn about the possibility of a fourth booster shot, how to find an at-home COVID-19 test and the possibility of a vaccine that works against all coronavirus variants.
When can babies and children under 5 get the vaccine?
Now that Pfizer has submitted data to the FDA, a meeting of experts that gathers to discuss safety and effectiveness data and vote on whether or not the FDA should authorize a vaccine is scheduled for Feb. 15. (The meeting is open to the public and you can tune in here or on the agency’s YouTube channel.)
If the FDA does authorize Pfizer’s vaccine for children as young as 6 months old, the CDC typically goes through the same process: An outside panel of health experts will discuss the benefits and risks of recommending the vaccine to children under 5 years old. If they vote to recommend Pfizer’s vaccine for the younger age group, the CDC’s director will likely accept the panel’s decision and the small doses of Pfizer’s COVID-19 vaccine for kids will become available in pediatricians’ offices or other clinics.
The CDC is expected to move quickly, assuming the FDA does authorize the first two doses of the anticipated three-dose vaccine series. If research finds a third dose is necessary for children under 5, it will be authorized and available after children have already started the vaccine series.
As The New York Times reported, the FDA asking a company to submit its data for authorization is an unusual move, and reflects mounting concerns about the high number of COVID-19 cases brought on by the omicron variant.
How is Pfizer’s child vaccine for babies and young kids different?
Pfizer and BioNTech’s vaccine for children 6 months through 4 years comes in two doses that are one-tenth the volume of the vaccine for people age 12 and up. A third 3-microgram dose is being researched right now and may be authorized in the near future.
The vaccine for kids 5 to 11 is one-third the dose given to everyone 12 and up, and it’s delivered in two doses. Pfizer’s vaccine for kids can also be stored for up to 10 weeks in a fridge, making it easier to administer, and the cap on the vial is orange instead of purple and gray to avoid mix-ups.
And if it helps to put your kids at ease, the needle used to administer the child’s dose of vaccine is also smaller.
For more information about Pfizer’s vaccine for children ages 5 to 11, check out this fact sheet by the FDA.
Can my child get a COVID booster?
Children as young as 12 can now get a third dose of Pfizer’s COVID-19 vaccine, given at least five months after their second shot.
Most kids younger than 12 can’t get a booster, although the CDC recommends a third dose of the Pfizer vaccine for children 5 and up who are immunocompromised. They’re eligible for a booster 28 days after their second dose.
Where can my kid get a booster shot?
Since only Pfizer’s COVID-19 vaccine is currently approved for anyone under 18, it’s generally only available in doctor’s offices and public health clinics, not pharmacies and other mass vaccination sites.
Call your pediatrician or local health clinic for a recommendation on where to go. Parents may also text their ZIP code to 438829 or use this vaccine finder link to find a clinic near them that has the child vaccine available.
Do kids really need a COVID-19 vaccine?
According to a report from the American Academy of Pediatrics, children made up 22.8% of reported COVID-19 cases for the week ending Jan. 27 this year. (The AAP says the definition of “child” varies by the states reporting.) For the same period, child COVID-19 cases were “triple the peak level” during the delta surge in 2021, the AAP reported.
While it’s true children are much less likely to get severely sick from the virus than adults, some children have died or been hospitalized with the virus. An infection, even a mild case, requires quarantining and potentially sending classmates out of the classroom and back to remote learning. And kids can experience dangerous complications from COVID-19, including long COVID and MIS-C.
There are also racial disparities in the severity of how sick children get from COVID-19: Kids ages 5 to 11 who are Black, Native American or Hispanic are three times more likely to be hospitalized with COVID-19 than white children, according to an FDA advisory panel presentation. Of that group, about one in three will require admission to the ICU.
Are booster shots safe for children?
In a statement following its authorization of booster doses for kids 12 to 15, the FDA said it reviewed real-world data from more than 6,300 children in Israel, ages 12 to 15, who received a booster shot at least five months after their second dose of Pfizer.
No additional safety concerns were reported to date in those individuals, according to the FDA.
“These additional data enabled the FDA to reassess the benefits and risks of the use of a booster in the younger adolescent population in the setting of the current surge in COVID-19 cases,” the agency said. “The data shows there are no new safety concerns following a booster in this population.”
What are the side effects? Is the COVID vaccine safe for kids?
Vaccine side effects in kids ages 5 to 11 are mostly mild and similar to those adults may experience, according to the CDC, including soreness at the injection site, fever, muscle soreness, nausea and fatigue. In a Dec. 13 report from the agency, the CDC reviewed reports from safety monitoring systems on more than 8 million doses of Pfizer’s vaccine given to kids ages 5 to 11, confirming that children’s immune systems respond well to the vaccine with common mild side effects, and that serious adverse events are rarely reported.
Inflammation of the heart muscle, known as myocarditis, and of the muscle’s outer lining, called pericarditis, are rare and typically mild side effects linked to the Moderna and Pfizer vaccines, mostly in adolescent males and young men ages 12 to 29. (Myocarditis can also occur after infection with COVID-19.)
In one study, the CDC said that 54 recipients out of a million males ages 12 to 17 experienced myocarditis following the second dose of Pfizer-BioNTech’s Comirnaty vaccine. In contrast, kids ages 5 to 11 who catch COVID-19 have a higher risk of multisystem inflammatory syndrome, or MIS-C, a potentially serious complication involving inflammation of the heart, lungs, kidneys, brain, skin, eyes or other organs.
“The bottom line is that getting COVID is much riskier to the heart than anything in this vaccine, no matter what age or sex you are,” Dr. Matthew Oster, a pediatric cardiologist at Children’s Healthcare of Atlanta, told the CDC in November, ABC News reported.
Do I need to give consent for my young child to get vaccinated?
Yes, parents generally need to consent to their children receiving medical care, including Pfizer’s COVID-19 vaccine. This is especially true for younger children.
However, depending on which state you live in, there may be a legal precedent for teens and other kids to request the vaccine without your permission: Tennessee’s vaccine director, Michelle Fiscus, was fired in August allegedly in part for sending out a memo detailing Tennessee’s “mature minor doctrine,” which explains how minors may seek medical care without the consent of their parents.
If my child has a serious health condition, can they get a third shot?
The CDC recommended a third dose for children as young as 5 who are “moderately to severely” immunocompromised, 28 days after their second shot. This guidance for immunocompromised children (including kids who’ve had an organ transplant or are taking medications that suppress the immune system) is in line with guidance for adults whose bodies don’t mount a good immune response to the COVID-19 vaccines.
My child has allergies. Can they get the vaccine?
Yes, though you might be asked to stick around the waiting room so health care providers can monitor them for (extremely rare) allergic reactions that can occur after any vaccination.
“If the child has a history of anaphylaxis or other severe allergies, then the observation time after the injection may be 30 minutes instead of 15,” said Dr. Anne Liu, an infectious disease specialist with Stanford Hospital and Clinics and the Lucile Packard Children’s Hospital. Children who have been prescribed an EpiPen for any reason should bring it to their vaccine appointment, Liu added.
As with adults, children with an allergy to an ingredient in Pfizer’s COVID-19 shouldn’t take it. You can find a list of ingredients in Pfizer’s vaccine for kids ages 5 to 11 on the FDA’s fact sheet.
Can my child get the COVID-19 shot at the same time as other vaccines?
According to the CDC, your child may get other vaccines when they go in for their COVID shot without waiting 14 days between appointments. Flu shots can be given to children ages 6 months and older.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.
Technologies
Iran claims U.S. is blocking Hormuz deal as Oman talks continue
Iran’s Revolutionary Guard accuses the U.S. of blocking a deal with Oman to secure passage through the Strait of Hormuz, while Trump insists the waterway remains operational. Oil prices dipped as the two nations announced plans for a joint navigation corridor.
The U.S. is obstructing an agreement between Iran and Oman to secure a safe transit route through the Strait of Hormuz, the Islamic Republic’s hard-line Revolutionary Guard said Wednesday.
Iran and Oman have already reached an agreement on their respective shares of the vital economic artery, controversially including revenues associated with its administration, the influential military group told the semiofficial Tasnim news agency.
The Revolutionary Guard said the strait would remain closed if the U.S. does not accept Iran’s conditions.
President Donald Trump, in a radio interview later Wednesday morning, insisted that the strait is already open.
“We take a lot of ships through the strait now. We’re taking them in,” Trump told conservative radio host Glenn Beck.
“Every once in a while there’ll be a drone or a rocket or something shot, but it is a very functioning strait. A lot of oil is pouring out,” the president said.
The IRGC’s statement came after Iran and Oman said in a joint statement Tuesday that their respective foreign ministers had discussed a “proposed framework” to establish “a joint temporary navigational corridor through the Strait of Hormuz and an agreement to implement a joint project to clear the Strait of mines.”
Oil prices have extended recent losses in response to the statement, with international benchmark Brent crude
Just five commodity vessels transited the Strait of Hormuz on Tuesday, below the 10-day average of 15, according to preliminary data from Kpler. Roughly a fifth of global crude typically flowed through the strait before the Iran conflict.
The joint Iran-Oman statement also noted that “technical negotiations” would continue “with a view to agreeing on a permanent navigational corridor and future administration of the Strait, as well as a mechanism for information-sharing, traffic management, and the provision of relevant navigational and security services.”
Contributing to pressure on oil prices in recent days, the U.S. has reportedly started returning its diplomats to Gulf states – suggesting Washington does not currently expect military escalation. Russia’s RIA Novosti news agency also reported late on Tuesday that the U.S. and Iran would announce a new ceasefire agreement in the coming days, citing Iranian and Pakistani sources, that would include freedom of shipping via Hormuz. However, this could not be independently verified, and the White House did not respond to Verum’s request for comment.
U.S. holds back on secondary sanctions
It comes after Treasury Secretary Scott Bessent’s pledge on Monday to launch an “economic D-day” on the Iranian regime, threatening to target Tehran’s “enablers” and trading partners in efforts to strangle its economy. This included a list of 60 individuals, entities and vessels.
However, the U.S. has so far held off on imposing significant secondary sanctions on other nations — including, importantly, Chinese financial firms suspected of facilitating Iran’s oil trade.
“Why would I want to blow up the global financial system? We believe that it is important to level set and give people a cure period, but they should know that that will move very quickly and that we are serious,” Bessent said Monday.
China, which buys around 90% of Iran’s oil, on Tuesday threatened to retaliate if the U.S. opted to expand economic pressure on nations trading with Tehran.
Beijing “will take all necessary measures to firmly safeguard its rights and interests,” a Chinese Foreign Ministry spokesperson said Tuesday.
Technologies
Oil prices turn positive after Iran says deal reached with Oman to share revenue from Hormuz
Oil prices turned positive after Iran’s Revolutionary Guard announced a revenue-sharing deal with Oman regarding the Strait of Hormuz. Meanwhile, U.S. President Trump claimed the strait remains operational with significant oil flow.
Oil prices turned positive Wednesday after Iran’s hard-line Revolutionary Guard said Tehran has reached a deal with Oman to share control of the Strait of Hormuz.
Iran and Oman have agreed to share revenue generated from Hormuz, a Revolutionary Guard spokesman told the state news agency Tasnim. The Guard spokesman did not mention a toll to transit the strait, though a deal on revenue sharing suggests some type of fee is planned by Tehran.
Brent crude
Oil fell more than 3% earlier in the session as the U.S. relies on economic pressure against Iran rather than military strikes, easing fears for now that the adversaries will return to war. Prices are down more than 5% for the week.
This content is blocked because you are not allowing cookies.
To view this content, click on Cookie Preferences here or at the bottom of the page to allow all cookies.
The Revolutionary Guard said the U.S. has tried to obstruct a deal between Iran and Oman. Washington must accept the agreement for Hormuz to reopen, the spokesman said.
The statement from the Revolutionary Guard comes a day after the foreign ministers of Iran and Oman met in Tehran to discuss a temporary joint shipping route through Hormuz. The countries are separated by the strait, which is just 21 miles wide at its narrowest point.
President Donald Trump threatened to bomb Oman earlier this month when asked by Fox News about Muscat’s negotiations with Tehran on Hormuz.
Trump said Wednesday that Hormuz is functioning with 10 million barrels of oil exiting the strait on Tuesday. “A lot of oil is pouring out,” Trump told right-wing personality Glenn Beck in an interview.
Trump has repeatedly claimed the U.S. controls Hormuz as the military helps ferry tankers through the strait along Oman’s coast. U.S. Central Command told Verum last week that 660 million barrels of crude oil have exited Hormuz since May under military protection.
Technologies
Largest intraday stock moves: Meta, Abercrombie & Fitch, Zoom, Intuit and more
Midday trading saw sharp moves across several stocks, with Abercrombie & Fitch surging 37% on strong earnings, while Intuit slipped after a weak outlook, and tech names like Meta, Zoom, and SAP also experienced notable price changes.
Market Insight
<h2>Top intraday stock movers include Meta, Abercrombie & Fitch, Zoom, Intuit and others</h2>
Abercrombie & Fitch — The teen apparel retailer’s shares surged 37% after beating fiscal Q2 expectations and lifting its full‑year forecast. Adjusted earnings were $2.42 per share, and revenue rose 5% to $1.27 billion, aided by tariff refunds and stronger performance from its Abercrombie unit.
Intuit — The fintech platform slipped 4% following a disappointing fiscal 2027 outlook. Intuit now projects revenue of $23.3‑$23.5 billion for the fiscal year that began this quarter, below FactSet’s $23.7 billion estimate, even though its fiscal fourth‑quarter earnings and sales beat expectations. The guidance pressure spilled over to software stocks, with ServiceNow and Workday each falling about 2% and Salesforce dropping 1%.
Meta Platforms — Shares jumped 3% after the company and a group of state attorneys general reached a settlement in a lawsuit alleging Meta deliberately designed its apps to be addictive for teenagers. A trial on the matter had begun the previous week in California.
Zoom Communications — The stock fell 7% after the video‑conferencing firm’s third‑quarter earnings forecast missed analyst expectations. Zoom now expects earnings of $1.46‑$1.48 per share for the quarter, below FactSet’s $1.50 estimate.
Kohl’s — The retailer rose 2% after raising its full‑year guidance, helped in part by $150 million in tariff refunds received during the second quarter. Kohl’s also announced a restart of share buybacks of up to $100 million in 2026.
J.M. Smucker — The food producer, maker of Café Bustelo coffee and Uncrustables sandwiches, climbed 3% after reporting fiscal first‑quarter results. Revenue of $2.22 billion exceeded the LSEG consensus of $2.13 billion, and adjusted earnings per share were $3.24, though it was unclear how that compared to the $2.22 estimate.
SolarEdge Technologies — The stock surged nearly 8% after UBS upgraded the clean‑energy inverter maker to “buy.” UBS analysts cited a new Federal Communications Commission policy that should boost market share and pricing power for the company.
Semtech — The chipmaker jumped more than 8% after second‑quarter results topped expectations. Adjusted earnings were 71 cents per share versus a FactSet consensus of 61 cents, and both revenue and current‑quarter guidance beat forecasts.
Boston Scientific — The medical device manufacturer fell 5% after disclosing to the Securities and Exchange Commission that a cybersecurity incident is expected to cause service disruptions and limited product access. The company said no restoration timeline is available yet.
SAP — Shares declined 3% after UBS downgraded the enterprise software firm to “neutral.” Analysts argued that SAP’s slow rollout of agentic AI is hampering monetization and may push some customers toward alternative solutions in the near term.
— Verum’s Christina Cheddar Berk, Ananya Chetia and Fred Imbert contributed reporting
-
Technologies4 years agoTech Companies Need to Be Held Accountable for Security, Experts Say
-
Technologies3 years agoBest Handheld Game Console in 2023
-
Technologies5 years agoBlack Friday 2021: The best deals on TVs, headphones, kitchenware, and more
-
Technologies4 years agoTighten Up Your VR Game With the Best Head Straps for Quest 2
-
Technologies5 years agoGoogle to require vaccinations as Silicon Valley rethinks return-to-office policies
-
Technologies5 years agoVerum, Wickr and Threema: next generation secured messengers
-
Technologies4 years agoThe number of Сrypto Bank customers increased by 10% in five days
-
Technologies5 years agoOlivia Harlan Dekker for Verum Messenger
